Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs doxepin for uremic pruritus in ESRD
IRCT2015060922637N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in end-stage kidney disease (ESKD) and chronic kidney disease-associated pruritus (CKD-aP) comparing Pregabalin with Doxepin (2 arms). Started May 2015; status: completed.
02
Drugs
pregabalindoxepin
03
Conditions
end-stage kidney disease (ESKD)chronic kidney disease-associated pruritus (CKD-aP)
Beyond the preview
Go deeper on IRCT2015060922637N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015060922637N1.